-
By Joyce Hanson, AdvisorOne |
October 24, 2012
ChartLabPro.com's mission is to provide an easy-to-use platform that won’t intimidate investors, no matter what their level of experience.
-
By Alexei Bayer |
November 23, 2011
In the third quarter, an unusual situation arose in U.S. financial markets: dividend yield on stocks surpassed the interest rate on the 10-year Treasury bond. While some technical analysts saw this as a strong “buy” signal, and the market did subsequently rally, the real explanation is probably far less favorable...
-
By Kenneth Silber, Research |
October 1, 2009
Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...
-
By Staff Writer |
January 31, 2003
S&P Rank: 4 Stars Good Prognoses for Drug Stocks